CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 49 filers reported holding CYTOSORBENTS CORP in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $966,000 | -38.4% | 125,000 | -35.6% | 0.89% | +9.5% |
Q4 2018 | $1,568,000 | -59.9% | 194,100 | -36.0% | 0.81% | -45.0% |
Q3 2018 | $3,913,000 | +33.0% | 303,300 | +17.5% | 1.47% | +24.7% |
Q2 2018 | $2,943,000 | +69.5% | 258,200 | +4.9% | 1.18% | +28.5% |
Q1 2018 | $1,736,000 | +53.9% | 246,200 | +41.8% | 0.92% | +55.9% |
Q4 2017 | $1,128,000 | +21.3% | 173,600 | +15.7% | 0.59% | +29.7% |
Q3 2017 | $930,000 | +33.2% | 150,000 | -3.2% | 0.45% | +49.3% |
Q1 2017 | $698,000 | +155.7% | 155,000 | +210.0% | 0.30% | +126.9% |
Q4 2016 | $273,000 | – | 50,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |